HSIC
Henry Schein, Inc.NASDAQHealthcare$73.94+1.23%ClosedMarket Cap: $8.70B
As of 2026-04-06
Valuation
P/E (TTM)
21.87
PEG
10.66
P/B
2.67
P/S
0.66
EV/EBITDA
12.25
DCF Value
$86.92
FCF Yield
6.4%
Div Yield
0.0%
Margins & Returns
Gross Margin
29.1%
Operating Margin
5.8%
Net Margin
3.0%
ROE
11.9%
ROA
6.7%
ROIC
6.7%
Income Statement
| Period | Revenue | Gross Margin | Operating Income | Net Income | EPS | Dividend |
|---|---|---|---|---|---|---|
| Q4 2025 | $3.44B | 28.9% | $186.0M | $101.0M | $0.85 | — |
| FY 2025 | $13.18B | 29.1% | $758.0M | $398.0M | $3.27 | — |
| Q3 2025 | $3.34B | 28.7% | $206.0M | $101.0M | $0.84 | — |
| Q2 2025 | $3.24B | 29.4% | $175.0M | $86.0M | $0.70 | — |
| Q1 2025 | $3.17B | 29.6% | $202.0M | $110.0M | $0.88 | — |
| Q4 2024 | $3.19B | 29.1% | $192.0M | $94.0M | $0.74 | — |
| FY 2024 | $12.67B | 29.7% | $729.0M | $390.0M | $3.05 | — |
| Q3 2024 | $3.17B | 29.3% | $205.0M | $99.0M | $0.78 | — |
| Q2 2024 | $3.14B | 30.5% | $174.0M | $104.0M | $0.80 | — |
| Q1 2024 | $3.17B | 30.0% | $160.0M | $93.0M | $0.72 | — |
| Q4 2023 | $3.02B | 28.7% | $60.0M | $18.0M | $0.14 | — |
| FY 2023 | $12.34B | 29.6% | $714.0M | $416.0M | $3.16 | — |